Skip to main content

Table 1 Pathological tumor characteristics of cN0 and unilateral cN1a PTC patients

From: Is total thyroidectomy with bilateral central neck dissection the only surgery for papillary thyroid carcinoma patients with clinically involved central nodes?

Pathological characteristics

cN0 no. (%)

Unilateral cN1a no. (%)

p-value

Total (n = 899)

793

106

 

Sex

 Female

605 (76.3)

81 (77.4)

0.808

 Male

188 (23.7)

25 (22.6)

Age (year)

 Mean ± SD

47.1 ± 11.9

43.4 ± 10.7

0.002

 < 55

565 (71.2)

91 (85.8)

 ≥ 55

222 (28.8)

15 (14.2)

Main tumor laterality

 Right

448 (56.5)

43 (40.6)

0.002

 Left

345 (43.5)

63 (59.4)

Tumor size (cm)

 Mean ± SD

1.17 ± 0.7

1.20 ± 0.5

0.603

 ≤ 1.0

392 (49.4)

44 (41.5)

 

 1.0–2.0

326 (41.1)

56 (52.8)

 

 2.0–4.0

70 (8.8)

6 (5.7)

 

 > 4.0

5 (0.6)

0 (0)

0.611

Bilaterality

 Absent

548 (69.1)

71 (67.0)

0.657

 Present

245 (30.9)

35 (33.0)

Multifocality

 Absent

592 (74.7)

70 (66.0)

0.059

 Present

201 (25.3)

36 (34.0)

BRAF mutation (n = 634)

 Absent

75 (13.1)

9 (14.8)

0.715

 Present

498 (86.9)

52 (85.2)

Extrathyroidal extension

 Absent

277 (34.9)

42 (39.6)

0.343

 Present

516 (65.1)

64 (60.4)

Chronic lymphocytic thyroiditis

 Absent

563 (71.0)

62 (58.5)

0.009

 Present

230 (29.0)

44 (41.5)

Number of retrieved central LNs (no.)

 Mean (range) ± SD

9.7 (1.0–34.0) ± 5

11.7 (2.0–36.0) ± 6

< 0.001

Central LN metastasis

 Absent

337 (42.5)

24 (22.5)

< 0.001

 Present

456 (57.5)

82 (77.4)

Ipsilateral central neck metastasis

 Absent

36 (7.9)

2 (2.4)

0.076

 Present

420 (92.1)

80 (97.6)

Contralateral central neck metastasis*

 Absent

297 (65.1)

51 (62.2)

0.609

 Present

159 (34.9)

31 (37.8)

Number of metastatic CLNs (no.)

 Mean(range) ± SD

2.22(1.0–20.0) ± 2.8

2.24(1.0–15.0) ± 2.9

0.004

5

375 (82.2)

56 (68.3)

 > 5

81 (17.8)

26 (31.7)

Retrieved CLNM size (mm)

 < 2.0

152 (33.3)

10 (12.2)

< 0.001

2.0

304 (66.7)

72 (82.8)

Loco-regional recurrence

 Absent

779 (98.2)

104 (98.1)

1.000

 Present

14 (1.8)

2 (1.9)

  1. PTC papillary thyroid carcinoma, cN0 no clinically involved central lymph node, cN1a clinically involved central lymph node, no number, SD standard deviation, LN lymph node, CLNM central lymph node metastasis
  2. *Patients with ipsilateral central neck metastasis and contralateral central neck metastasis simultaneously OR with contralateral central neck metastasis only were counted